Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,38749,1577,1.70 [1.46-1.98],7.647679209534562e-12
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38130,371,2.59 [1.95-3.44],5.364292587780152e-11
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,42276,294,1.43 [1.02-2.01],0.037620945250028
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,29218,1314,1.92 [1.62-2.28],8.412719724501426e-14
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,42178,196,1.52 [1.02-2.29],0.0413697258281114
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39525,150,2.28 [1.49-3.51],0.0001682137348077
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",44281,194,1.57 [1.05-2.35],0.0275307732215745
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,44287,131,1.35 [0.80-2.25],0.2587947501174003
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38620,100,2.82 [1.78-4.46],9.636204274090548e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,42916,207,2.11 [1.46-3.06],7.568449102512172e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,42842,133,1.80 [1.11-2.94],0.0182623438292391
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,44417,120,1.71 [1.04-2.81],0.0338894307165542
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,44416,148,1.68 [1.09-2.59],0.0184874401040163
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",44405,137,1.67 [1.06-2.62],0.0267765390904078
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,43839,92,1.25 [0.68-2.29],0.4771142834745705
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42358,708,1.66 [1.34-2.06],2.878200661940481e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41894,244,1.82 [1.29-2.56],0.0005698600800231
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42136,486,1.77 [1.38-2.27],7.13532172807184e-06
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",35622,109,1.74 [1.01-3.00],0.0445503984138097
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35607,94,0.76 [0.39-1.49],0.4278247575564411
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",35967,454,1.26 [0.94-1.68],0.1235034113257811
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",35980,467,1.27 [0.95-1.69],0.1018903459568447
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",20182,585,1.28 [0.99-1.64],0.0559905249104632
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16110,194,1.37 [0.89-2.11],0.1569441671631763
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35607,94,2.49 [1.64-3.78],2.0544996213260023e-05
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,39782,1342,1.78 [1.52-2.09],2.026059912017239e-12
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",42220,580,1.44 [1.13-1.85],0.0036822089864782
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43613,207,1.36 [0.90-2.05],0.1428874972995797
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",44561,195,1.79 [1.20-2.66],0.0041799188872231
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Rectum,44081,120,1.36 [0.79-2.35],0.2645022589531466
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,44564,114,1.33 [0.76-2.34],0.3147939932454993
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Stomach,44651,83,0.99 [0.50-1.97],0.974223602483418
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm,44175,512,0.89 [0.67-1.18],0.4210125092396486
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,44576,197,1.07 [0.69-1.66],0.7678878059993771
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,44581,154,0.94 [0.57-1.55],0.8037827493782126
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",44479,93,1.04 [0.55-1.98],0.9025557724215588
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma, any site",44484,92,1.07 [0.56-2.03],0.8449735478110958
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi,44327,339,0.94 [0.67-1.32],0.7338081678315415
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,44597,154,0.93 [0.56-1.53],0.7633748552518336
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Other benign neoplasms of skin,44405,314,1.09 [0.77-1.53],0.642453719712677
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of breast,24095,121,1.07 [0.62-1.86],0.8030880254709445
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Leiomyoma of uterus,23665,885,1.07 [0.87-1.31],0.5358917039805033
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,42475,332,1.43 [1.04-1.97],0.0257635552553627
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,41924,588,1.55 [1.22-1.98],0.000391506686402
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,41924,588,1.55 [1.22-1.98],0.000391506686402
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),38674,769,1.78 [1.44-2.20],9.399572085480285e-08
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43692,122,1.42 [0.84-2.39],0.1898169613729311
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,44143,135,1.42 [0.88-2.29],0.1482601340238496
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,36133,1968,1.31 [1.13-1.51],0.0002926235264977
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42081,926,1.63 [1.35-1.98],6.566761207142512e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,40630,207,1.95 [1.34-2.83],0.0004281096352759
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,42613,190,2.49 [1.77-3.50],1.7819520032666201e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,40609,186,1.83 [1.22-2.75],0.0033732323448445
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,41352,929,1.50 [1.22-1.84],0.0001130948573325
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,41326,903,1.50 [1.22-1.84],0.0001448178209525
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,41369,302,1.22 [0.83-1.78],0.3050262657188193
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",41371,298,1.22 [0.83-1.79],0.3037738364747449
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,35838,1673,1.17 [1.00-1.38],0.0497357847827315
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34380,215,1.15 [0.75-1.77],0.5100800311110749
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,35715,1550,1.19 [1.01-1.41],0.0390878501308181
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34252,87,1.50 [0.79-2.85],0.211257909161179
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",34303,138,2.34 [1.59-3.46],1.8861391992865608e-05
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Any mental disorder,37839,1126,1.41 [1.17-1.70],0.0002329541999938
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",37122,409,1.91 [1.43-2.56],1.2926440704594055e-05
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43958,299,1.65 [1.21-2.24],0.0014718476623471
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",44063,219,1.91 [1.36-2.68],0.0001924320313441
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,41571,104,1.61 [0.90-2.85],0.1063450145827404
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",44490,104,1.47 [0.89-2.41],0.1307805677949505
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",36817,104,1.63 [0.92-2.91],0.0955101548576516
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Alcohol dependence,41595,128,2.11 [1.31-3.38],0.0020417401910495
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Smoking dependency,41504,110,2.33 [1.40-3.90],0.0011988143715601
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36813,100,1.21 [0.66-2.25],0.5367036803301185
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",37261,548,1.37 [1.06-1.78],0.017997682255947
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Depression,41901,481,1.38 [1.05-1.81],0.0219796152972468
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Depression or dysthymia,36851,420,1.46 [1.09-1.96],0.0108676074975985
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",36932,219,0.80 [0.52-1.23],0.3184634204288674
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Other anxiety disorders,42130,112,0.66 [0.36-1.20],0.176351537732033
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Neurological diseases,38415,2561,1.27 [1.13-1.44],0.0001207658224336
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34909,247,1.40 [0.96-2.05],0.0777703041183541
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,44389,196,1.40 [0.94-2.10],0.1017005050280242
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42369,825,1.48 [1.21-1.82],0.0001831823093229
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Epilepsy,41801,257,1.71 [1.23-2.39],0.0013887350157356
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Migraine,41685,141,1.36 [0.82-2.26],0.2284288492550621
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",44130,126,1.20 [0.70-2.04],0.5086508085456138
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,43236,135,1.31 [0.78-2.19],0.3127550860121184
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other sleep disorders,41827,283,1.39 [0.97-2.00],0.0767897128676029
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Sleep apnoea,43673,216,1.28 [0.84-1.93],0.2525966132264091
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42637,1147,1.07 [0.89-1.28],0.4902590486163263
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41699,209,1.11 [0.73-1.70],0.6163273739484092
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,42149,659,0.97 [0.76-1.24],0.7930383905149456
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,44157,144,1.29 [0.79-2.11],0.3127379813347145
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hemiplegia,44114,101,1.41 [0.80-2.51],0.237846113027373
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other neurological diseases,43807,206,1.45 [0.98-2.16],0.0661492401601654
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",43503,650,0.96 [0.75-1.22],0.7214423549923468
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,43226,373,0.92 [0.66-1.27],0.5996076331248794
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42988,135,1.03 [0.61-1.76],0.9013512216783336
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,43057,204,0.81 [0.52-1.26],0.3430233849018383
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42986,133,1.07 [0.63-1.84],0.7954206626863033
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,38465,274,1.46 [1.01-2.11],0.044667248835892
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,38885,694,1.00 [0.79-1.27],0.9944397886958964
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,42904,345,1.03 [0.74-1.44],0.8571742600306228
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,44074,70,2.15 [1.15-4.03],0.0169164963230864
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3776,70,1.49 [0.74-2.98],0.2643872231160298
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",40368,70,2.29 [1.23-4.26],0.0086001735925081
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43472,164,0.81 [0.49-1.33],0.3991565063466947
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,43395,87,0.81 [0.41-1.60],0.5391222569114272
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43445,142,0.84 [0.49-1.42],0.5073117975763983
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43715,173,0.78 [0.48-1.26],0.3040883257950683
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,44457,229,0.96 [0.64-1.44],0.8378345866263883
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,43173,185,0.64 [0.40-1.03],0.0654722058172046
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,31551,5565,1.55 [1.40-1.72],1.2846611255890713e-17
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43572,122,2.07 [1.31-3.29],0.0019464874624527
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",33270,3822,1.45 [1.30-1.63],7.860638671135175e-11
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,33312,3864,1.45 [1.29-1.62],1.182889248239593e-10
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29545,97,1.80 [1.02-3.19],0.0428899450917826
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",40852,2003,1.11 [0.96-1.29],0.153788198218141
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Angina pectoris,40044,1195,1.04 [0.86-1.25],0.6899256101541746
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42843,393,1.10 [0.80-1.51],0.5477116230110466
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43242,792,0.99 [0.79-1.24],0.9428591031335196
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",44412,163,0.86 [0.53-1.42],0.5665168950370232
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39347,498,0.97 [0.73-1.29],0.8300018127523028
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,40398,1581,1.10 [0.94-1.30],0.2404641611077921
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,43197,194,2.29 [1.60-3.28],5.546130958227716e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43412,403,1.81 [1.38-2.39],2.490141647865826e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,43175,172,2.30 [1.59-3.33],1.0181206422890104e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,43177,174,2.30 [1.59-3.32],9.23823040097978e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29613,165,2.31 [1.58-3.37],1.5563101172657888e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,37138,104,1.78 [1.01-3.13],0.0463476497613743
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Conduction disorders,37241,207,1.56 [1.03-2.36],0.035693902722294
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24696,203,1.60 [1.06-2.44],0.0270776272294219
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,25252,759,2.40 [1.93-2.98],3.6495795310812724e-15
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arrhythmias,37150,116,2.15 [1.32-3.48],0.001958141252555
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37199,165,1.87 [1.20-2.90],0.0055090188401142
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",42828,359,2.05 [1.54-2.74],1.0763757464059694e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",43104,263,1.38 [0.96-1.99],0.0823062329443617
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",43162,221,1.53 [1.04-2.27],0.0324276243498626
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",43294,193,1.37 [0.89-2.10],0.153296560557345
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42606,129,1.11 [0.65-1.90],0.7067785795276418
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42698,221,2.07 [1.49-2.89],1.657659546422589e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),42111,247,1.86 [1.32-2.63],0.0004560120786608
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,42072,208,2.00 [1.39-2.88],0.0001829685410229
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",44269,200,2.09 [1.46-3.01],6.262415520347116e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Varicose veins,42696,832,1.07 [0.86-1.32],0.5645999976287888
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypotension,42635,143,1.27 [0.77-2.12],0.3503196016047494
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,35642,3590,1.52 [1.36-1.69],4.979091094946056e-14
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,44315,190,1.46 [0.97-2.19],0.0666592944218061
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,41466,396,1.75 [1.31-2.34],0.0001520568848199
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",41415,345,1.74 [1.28-2.38],0.0004422487269386
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43032,442,1.42 [1.07-1.87],0.0144188375107676
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43026,436,1.41 [1.06-1.86],0.0173827360311751
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,43231,1057,1.31 [1.08-1.57],0.0049483424369229
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic sinusitis,42342,168,1.43 [0.92-2.24],0.1133310201976946
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Nasal polyp,42389,215,1.54 [1.04-2.30],0.0322934331105724
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",42847,673,1.27 [1.01-1.61],0.0409394827980022
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Deviated nasal septum,42491,317,1.31 [0.93-1.83],0.1196143986598417
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20548,108,1.76 [0.99-3.12],0.0547563553105176
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,39845,1758,1.38 [1.19-1.60],1.261179303449978e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Early onset COPD,42606,301,1.87 [1.38-2.55],5.659088092768344e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",42648,343,1.85 [1.38-2.48],3.961354751380426e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",42648,343,1.85 [1.38-2.48],3.961354751380426e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",41601,1446,1.18 [1.00-1.38],0.0478858125326486
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Asthma,31891,1446,1.28 [1.08-1.51],0.003603231970319
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",31433,1446,1.30 [1.10-1.53],0.002384633497242
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",31870,1425,1.29 [1.09-1.52],0.0033631481846074
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43981,175,2.36 [1.59-3.50],1.838902651500436e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Interstitial lung disease,42005,135,2.73 [1.86-4.00],2.822025621225924e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",44118,135,2.69 [1.83-3.96],5.519858830999273e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41993,123,2.77 [1.86-4.12],5.151326490071761e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,41041,188,1.97 [1.33-2.91],0.000681579340969
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,41267,414,1.89 [1.45-2.47],3.391359892676104e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,42449,193,2.32 [1.65-3.28],1.679886237193543e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,30431,10079,1.23 [1.14-1.33],1.0511178145877873e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43737,732,1.29 [1.03-1.60],0.0238536460110474
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,44594,153,1.14 [0.70-1.86],0.5853053469777885
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impacted teeth,44599,141,1.28 [0.78-2.09],0.3327511004622373
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Dental caries,43198,193,1.76 [1.21-2.56],0.0030403966661553
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,43181,176,1.02 [0.64-1.62],0.9371224026618628
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,44578,172,1.14 [0.72-1.81],0.5673737466902099
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,43170,165,1.46 [0.93-2.29],0.0965265796322975
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42715,137,1.16 [0.69-1.94],0.5819921961710102
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,44449,94,1.09 [0.58-2.05],0.7871587175119134
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,34021,471,1.55 [1.18-2.02],0.0014669935277179
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",37302,3752,1.29 [1.16-1.43],2.452463630304511e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophagitis,34144,594,1.34 [1.04-1.72],0.0222083531243985
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,34772,1222,1.30 [1.09-1.55],0.0038443801914513
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33684,134,1.80 [1.14-2.82],0.0109402061636251
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33919,369,1.51 [1.10-2.05],0.0098130614085259
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33653,103,1.76 [1.01-3.07],0.0462936054257369
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastric ulcer,33808,258,1.44 [1.00-2.08],0.052921285455539
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Duodenal ulcer,33773,223,1.72 [1.18-2.51],0.0044136577337087
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",44417,159,1.49 [0.94-2.36],0.090221097305368
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic gastritis,33771,221,1.19 [0.79-1.80],0.4042326186424037
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),34947,1397,1.27 [1.08-1.50],0.0048167187695814
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of appendix,44374,221,0.82 [0.54-1.26],0.3631776089178027
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Functional dyspepsia,34301,751,1.11 [0.88-1.40],0.3707472555620219
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,33840,290,1.44 [1.02-2.05],0.0407034865448297
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,44355,278,1.31 [0.92-1.87],0.1339901110584688
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute appendicitis,44332,179,0.91 [0.57-1.45],0.6898694033380948
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Hernia,39131,2826,1.07 [0.94-1.21],0.3046251558694638
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Inguinal hernia,37349,1044,0.88 [0.72-1.08],0.2206739413217318
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Umbilical hernia,36520,215,0.91 [0.59-1.40],0.6562818021201255
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ventral hernia,36475,170,1.01 [0.63-1.63],0.963445349552205
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,37808,1503,1.29 [1.10-1.52],0.0017146457414141
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42955,1323,1.38 [1.17-1.62],0.0001142298464385
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestines,35037,3468,1.23 [1.10-1.37],0.0002665655537331
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",44062,107,2.26 [1.50-3.40],8.777106871901568e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",44532,144,2.32 [1.62-3.32],4.744137441554642e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn disease,41776,144,2.33 [1.62-3.33],4.035515271221544e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,41742,110,2.51 [1.71-3.69],3.0138329949972897e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",44408,236,1.55 [1.07-2.24],0.0200085109793934
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcerative colitis,41868,236,1.58 [1.09-2.29],0.014860316178384
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41842,210,1.66 [1.13-2.44],0.0092887544371553
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42710,1078,1.31 [1.10-1.58],0.0033185344516751
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42698,1066,1.30 [1.08-1.56],0.0057066540829053
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31741,172,1.13 [0.71-1.80],0.6170823362335345
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal stricture,43842,172,1.12 [0.70-1.79],0.6367359496742881
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31684,115,1.58 [0.94-2.67],0.0863474965764642
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,32603,1034,1.24 [1.03-1.51],0.0265892263860247
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31858,289,1.36 [0.97-1.90],0.0750907395211736
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,32064,495,1.37 [1.05-1.78],0.0204459958275461
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Constipation,41880,446,1.26 [0.95-1.68],0.1042895522456305
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43863,157,1.37 [0.87-2.16],0.1707799172434251
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31824,255,1.20 [0.82-1.75],0.3511479855472516
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31698,129,1.37 [0.81-2.30],0.2388132751928225
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33092,1523,1.19 [1.01-1.40],0.0335850667506512
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestine,32040,471,1.12 [0.84-1.49],0.4359918861915013
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43838,132,1.44 [0.89-2.35],0.139429777784598
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,43231,210,3.40 [2.49-4.64],1.3332857687432775e-14
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,43135,114,2.70 [1.80-4.06],1.78163447453885e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42251,1055,1.40 [1.16-1.68],0.0004069533093553
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholelithiasis,42040,844,1.32 [1.07-1.62],0.0099435064958964
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholecystitis,41365,169,1.36 [0.86-2.15],0.1825842563262982
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,41279,83,1.59 [0.87-2.91],0.1301291694610868
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis,41307,111,2.29 [1.45-3.64],0.0004111787725886
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),44333,111,2.22 [1.40-3.51],0.0007092711263956
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,42249,534,1.61 [1.26-2.05],0.0001151064451302
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,41834,119,1.22 [0.71-2.09],0.4787366008305869
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Coeliac disease,41814,99,1.19 [0.65-2.17],0.5750781184025406
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41798,83,1.93 [1.10-3.39],0.021269511999782
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42058,343,1.62 [1.20-2.18],0.0016786151665489
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,GI-bleeding,42046,331,1.57 [1.16-2.14],0.003956679687012
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,39199,2692,1.20 [1.06-1.36],0.0036064233869686
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43859,190,1.18 [0.76-1.84],0.4527680365884413
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43924,794,1.08 [0.86-1.34],0.5060843996079538
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,41916,991,1.13 [0.93-1.38],0.2178493701332947
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,43062,691,1.53 [1.22-1.92],0.0002156824941439
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",42523,152,1.68 [1.06-2.66],0.0287141703127199
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42812,441,1.55 [1.17-2.05],0.0021759945342396
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,44148,156,1.45 [0.91-2.32],0.1147126907994417
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,44112,120,1.91 [1.19-3.08],0.0076778329990479
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,44085,93,2.11 [1.27-3.50],0.0039415556086261
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,43233,103,1.02 [0.56-1.87],0.943859380153107
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,43759,629,1.06 [0.83-1.36],0.62973364523472
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,41082,157,0.92 [0.56-1.53],0.7604670467362517
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,41096,171,1.34 [0.86-2.10],0.2005009272060223
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,41056,131,1.44 [0.88-2.37],0.1496580584546796
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",41304,379,0.85 [0.61-1.18],0.3235846037572509
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,41268,343,0.85 [0.60-1.19],0.3379569665130042
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,32173,6934,1.17 [1.07-1.27],0.0004341764058047
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,34977,4032,1.12 [1.01-1.24],0.0370112627865133
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,40242,2111,1.13 [0.98-1.29],0.0904822324666692
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31212,267,2.46 [1.83-3.29],1.7660854742866463e-09
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,31742,797,1.62 [1.32-2.00],5.403406995232878e-06
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43908,256,2.48 [1.87-3.30],3.990960450151274e-10
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43924,232,2.66 [1.99-3.55],3.104176018085281e-11
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,32930,1985,1.11 [0.95-1.28],0.1860442004726983
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",37398,1985,1.07 [0.92-1.24],0.3719891952129495
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31066,121,2.01 [1.18-3.44],0.0104686214531424
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43678,117,1.80 [1.05-3.09],0.0317849693416263
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,31314,369,0.93 [0.67-1.30],0.663758158183722
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31066,121,1.38 [0.79-2.41],0.2513220754909887
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,31437,492,1.01 [0.76-1.35],0.9389310006080376
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",44357,248,0.98 [0.66-1.46],0.927058014960171
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,31860,915,1.08 [0.87-1.34],0.4856084951138537
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,31611,666,1.02 [0.79-1.30],0.9017106746572544
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33198,2253,1.02 [0.89-1.18],0.7411372247596961
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),31066,121,0.52 [0.29-0.94],0.0314683507572879
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),31354,409,0.73 [0.53-1.01],0.0599106215292527
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,31037,92,0.87 [0.44-1.71],0.6892429888048179
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),31051,106,1.08 [0.58-1.99],0.8076878397169167
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31791,846,1.00 [0.80-1.25],0.981503180942678
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31675,730,1.00 [0.79-1.27],0.9982487848898576
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34573,486,1.42 [1.09-1.86],0.0093026743494254
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,43652,246,2.50 [1.87-3.34],7.880474604723381e-10
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43503,97,3.07 [2.08-4.54],1.5964583229799162e-08
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38651,114,0.95 [0.53-1.70],0.8579686067603347
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,39064,527,0.95 [0.72-1.25],0.7091435922980243
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,40158,1621,0.98 [0.83-1.14],0.7770233833860547
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,38872,335,1.04 [0.74-1.46],0.8405351130793994
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38686,149,1.11 [0.67-1.84],0.677337919895703
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",39814,1277,1.01 [0.85-1.20],0.9237666359068202
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38626,89,0.88 [0.45-1.72],0.7185344691635102
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38944,407,1.00 [0.73-1.36],0.9913406444683772
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38708,171,0.89 [0.55-1.45],0.6449256187894358
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38673,136,1.25 [0.75-2.09],0.3894973868968757
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38774,237,1.31 [0.89-1.92],0.1684983645973248
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38651,114,1.42 [0.84-2.41],0.1953712017589177
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,39072,535,0.86 [0.65-1.13],0.2824903055704616
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38674,543,1.13 [0.87-1.47],0.3715358349618528
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,38248,117,1.67 [1.00-2.79],0.0509488201679928
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,38284,153,1.29 [0.79-2.11],0.3045874596599398
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,38307,176,0.86 [0.54-1.39],0.5476767827140647
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",38220,89,1.11 [0.58-2.12],0.7603370534565156
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,38333,202,1.10 [0.71-1.70],0.6839456618698709
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],38312,181,1.06 [0.67-1.70],0.8011748493519124
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38579,448,1.27 [0.96-1.69],0.0979930189970689
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,38231,100,1.79 [1.06-3.02],0.0301308678218648
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,38260,129,0.92 [0.53-1.60],0.7726946634687162
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,38343,212,1.24 [0.82-1.87],0.3156877918657349
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,38240,109,0.95 [0.53-1.72],0.8722447376105129
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",38916,785,1.04 [0.84-1.30],0.7056929779577195
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38429,298,1.02 [0.71-1.46],0.9252466272153744
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38558,427,1.10 [0.82-1.48],0.5334848190462904
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41353,304,1.40 [1.00-1.97],0.0526024196631246
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,41722,673,1.43 [1.14-1.79],0.0019974182647634
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,41131,82,1.72 [0.95-3.09],0.0715458711284564
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,41146,97,1.09 [0.58-2.06],0.7778041803462892
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,41222,173,1.38 [0.88-2.16],0.1558450769766024
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,35576,7351,1.03 [0.94-1.12],0.5268284594541597
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17678,1083,1.10 [0.90-1.34],0.3320482656170219
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,40324,377,1.30 [0.95-1.77],0.1008065844716222
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,40059,112,0.80 [0.44-1.46],0.461353819090515
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,40558,80,1.47 [0.77-2.82],0.2438010512874242
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,40561,83,2.56 [1.58-4.15],0.0001375802322544
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,40577,99,1.71 [0.97-3.00],0.0633765495801703
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,44011,412,1.14 [0.84-1.55],0.3836708864190401
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43910,114,1.76 [1.06-2.92],0.0296898514886366
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43893,294,1.32 [0.93-1.87],0.1229609517273987
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,43744,145,0.85 [0.50-1.44],0.5491190927130324
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,40857,1808,1.06 [0.92-1.24],0.4118808597992396
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cystitis,39204,155,1.39 [0.87-2.22],0.1737094282736641
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,39186,137,0.85 [0.49-1.46],0.5513345446531157
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39516,467,1.52 [1.15-2.00],0.0030010480386699
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,39247,198,1.21 [0.78-1.87],0.3983534104825064
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40235,1186,1.01 [0.84-1.22],0.8991290440442922
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,17084,489,1.11 [0.83-1.49],0.4612949251240951
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16683,88,1.72 [0.93-3.18],0.0816150666147912
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydrocele,16683,88,1.48 [0.79-2.79],0.2254644202127286
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16729,134,1.30 [0.76-2.20],0.3377256751093387
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16729,134,1.20 [0.70-2.05],0.5024405800239088
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16770,175,1.01 [0.63-1.63],0.9700556566133492
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23883,425,1.00 [0.74-1.35],0.9926124673846336
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23591,133,0.99 [0.58-1.69],0.9589753614346088
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23602,144,0.87 [0.52-1.47],0.6130459657322505
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23564,106,1.50 [0.89-2.53],0.1299027265236273
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23818,487,0.95 [0.71-1.26],0.6980809841419201
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23448,117,0.80 [0.45-1.44],0.4634979958838332
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23546,215,1.16 [0.77-1.75],0.4777622601937634
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22028,4030,0.95 [0.85-1.05],0.3139597334428361
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Endometriosis,18310,312,0.92 [0.65-1.32],0.6518543419578473
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,18086,88,0.72 [0.37-1.42],0.3442984922001656
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18144,146,1.06 [0.64-1.76],0.8312050743939124
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18699,701,0.80 [0.63-1.03],0.0789494838864902
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18347,349,0.77 [0.54-1.08],0.1258906288441177
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18835,837,0.99 [0.79-1.23],0.9022695530639084
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18271,273,1.09 [0.74-1.58],0.6690613656685729
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18385,387,1.19 [0.87-1.63],0.2784936225222054
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,18086,88,1.42 [0.77-2.63],0.2646117053163215
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,18165,167,0.78 [0.47-1.27],0.312629663265159
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",24115,233,0.89 [0.59-1.34],0.5789302695303996
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,24125,221,0.89 [0.58-1.35],0.5747194007541544
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,24145,121,0.81 [0.46-1.43],0.4721222773689255
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",24136,133,0.82 [0.48-1.42],0.4846992015214744
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18125,127,0.97 [0.56-1.70],0.926093438802214
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18102,104,1.48 [0.84-2.62],0.1763682215264218
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18125,127,0.93 [0.54-1.63],0.8094242472153472
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Irregular menses,24054,408,0.90 [0.66-1.22],0.4814056375327877
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",19181,1183,1.00 [0.83-1.21],0.99505318623102
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18771,773,1.12 [0.89-1.40],0.3308105268503427
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",24131,176,1.25 [0.80-1.93],0.3240439995187857
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18407,409,0.82 [0.60-1.12],0.2091537425631203
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18272,274,1.10 [0.76-1.59],0.6240411612169241
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18795,797,1.25 [1.00-1.57],0.0509467326263854
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female infertility,18086,88,0.98 [0.51-1.91],0.9629015407162064
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",18079,81,1.01 [0.50-2.00],0.9886490546653472
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,24141,733,0.90 [0.71-1.15],0.4129486968457061
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,24148,1014,0.87 [0.70-1.08],0.2070508420534096
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,24142,395,0.91 [0.66-1.24],0.5493245562808797
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23858,111,1.02 [0.58-1.79],0.952239832857529
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23904,157,1.17 [0.75-1.84],0.4888676702558534
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23887,140,0.75 [0.45-1.27],0.2869144329418774
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",24158,144,0.88 [0.53-1.47],0.6291296831832519
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,24160,141,0.83 [0.49-1.40],0.4779253910303316
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,24157,365,0.97 [0.70-1.35],0.8572210629239575
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23900,108,0.94 [0.53-1.69],0.8434990666051594
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23995,203,0.74 [0.47-1.15],0.1770060679010483
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23533,125,1.15 [0.68-1.94],0.5996044296403491
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23580,172,1.04 [0.66-1.64],0.8595262149452867
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23611,203,0.98 [0.64-1.50],0.929202937002608
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23530,122,0.65 [0.36-1.16],0.1471054781792387
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,23523,115,0.89 [0.51-1.58],0.6990589924452384
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23534,126,0.73 [0.42-1.28],0.2749043135651727
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,23326,192,0.73 [0.45-1.17],0.1853987835290091
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23513,379,0.81 [0.58-1.13],0.2102521721784096
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23696,562,0.90 [0.68-1.19],0.4552640522929471
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",24163,147,1.02 [0.62-1.67],0.9499987754705064
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22934,113,1.02 [0.57-1.80],0.9562989427250256
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",23219,85,1.11 [0.58-2.11],0.7612474107597824
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,24168,289,0.64 [0.44-0.93],0.020904260993993
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,24102,223,0.52 [0.33-0.80],0.0028417451684011
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",24157,216,0.87 [0.57-1.33],0.5227510664240123
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",24147,206,0.91 [0.59-1.40],0.6795620603152508
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43981,104,0.84 [0.45-1.56],0.5840269363467394
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,40323,1020,1.10 [0.90-1.34],0.3373853065914323
